Infectious disease · Phase II

Top sponsors

• BRIGHT MINDS BIOSCIENCES 27 programs
• United Therapeutics Europe 23 programs
• Chinese Academy of 16 programs
• Takeda 16 programs
• Vir Biotechnology 15 programs
• Vertex Pharmaceuticals (Australia) 12 programs
• Sinovac Research and 11 programs
• GSK Glaxo Smith 10 programs
• ENANTA PHARMACEUTICALS 8 programs
• Arrowhead Pharmaceuticals Ireland 7 programs
• Regeneron UK 7 programs
• Anaxis Pharma 6 programs

1. Gamma-retroviral vector MP71 MC2 TCR16-3D9

   Disc Medicine

   advanced melanoma or HNSCC

   phase 2 · small molecule · active

   1 trial →

2. Gatifloxacin 0.3% ophthalmic solution

   Allergan Pharmaceuticals International Limited

   Acute Bacterial Corneal Ulcers

   phase 2 · small molecule · completed

   1 trial →

3. Group A FMP2.1/AS01B

   United Therapeutics Europe Ltd

   Malaria

   phase 2 · mab · completed

   1 trial →

4. HB-adMSC

   United Therapeutics Europe Ltd

   COVID-19

   phase 2 · mab · terminated

   1 trial →

5. HEART to HAART

   BRIGHT MINDS BIOSCIENCES INC.

   HIV

   phase 2 · other · completed

   1 trial →

6. HEC110114 tablet

   Sunshine Guojian Pharmaceutical (Shanghai) Co.,

   Chronic Hepatitis C

   phase 2 · small molecule · completed

   2 trials →

7. HEC121120 tablets

   Sunshine Guojian Pharmaceutical (Shanghai) Co.,

   Hepatitis B, Chronic

   phase 2 · small molecule · terminated

   1 trial →

8. HEC96719

   Sunshine Guojian Pharmaceutical (Shanghai) Co.,

   Non-Alcoholic Steatohepatitis

   phase 2 · small molecule · completed

   1 trial →

9. HH-003(20mg/kg)

   Huahui Health

   Chronic Hepatitis Delta Virus Infection

   phase 2 · mab · completed

   1 trial →

10. Hepatitis A Vaccine

    Takeda

    Healthy Volunteers

    phase 2 · mab · completed

    1 trial →

11. Human COVID-19 immunoglobulin (pH4) for intravenous injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 · mab · active

    1 trial →

12. Hydroxychloroquine (HCQ)

    Teva Pharma GmbH

    COVID-19

    phase 2 · small molecule · terminated

    1 trial →

13. IMC-M113V

    Immunocore Ireland Limited

    Chronic HIV infection

    phase 2 · small molecule · active

    1 trial →

14. ION224

    IONIS PHARMACEUTICALS INC

    Steatohepatitis, Nonalcoholic

    phase 2 · small molecule · completed

    1 trial →

15. IONIS-HBVRx

    IONIS PHARMACEUTICALS INC

    Hepatitis B

    phase 2 · small molecule · completed

    1 trial →

16. ISIS 14803

    IONIS PHARMACEUTICALS INC

    Hepatitis C, Chronic

    phase 2 · small molecule · completed

    1 trial →

17. ISIS 14803-CS3

    IONIS PHARMACEUTICALS INC

    Hepatitis C, Chronic

    phase 2 · small molecule · completed

    1 trial →

18. ISIS 721744

    IONIS PHARMACEUTICALS INC

    Covid19

    phase 2 · small molecule · completed

    1 trial →

19. Ibezapolstat

    Acurx Pharmaceuticals

    Clostridium Difficile Infection Recurrence

    phase 2 · small molecule · active

    1 trial →

20. Ibezapolstat

    Acurx Pharmaceuticals

    Clostridium Difficile Infection

    phase 2 · small molecule · completed

    1 trial →

21. Ibrutinib

    United Therapeutics Europe Ltd

    Asymptomatic COVID-19 Infection Laboratory-Confirmed

    phase 2 · small molecule · terminated

    1 trial →

22. Imdusiran

    Arbutus Biopharma Corp

    Hepatitis B, Chronic

    phase 2 · small molecule · terminated

    1 trial →

23. Imdusiran (AB-729)

    Arbutus Biopharma Corp

    Chronic Hepatitis B

    phase 2 · small molecule · active

    1 trial →

24. Immunization with P. vivax irradiated sporozoites

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria

    phase 2 · mab · completed

    1 trial →

25. Infusion of MSC

    Lxo Ireland Designated Activity Company

    Discordant Immunological Response in HIV Infected Subjects

    phase 2 · small molecule · completed

    1 trial →

26. Interactive injection and sexual risk intervention

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 · other · completed

    1 trial →

27. Interferon Beta-1B

    The University of Hong Kong

    COVID

    phase 2 · small molecule · completed

    1 trial →

28. Intervention Condition

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 · other · completed

    1 trial →

29. Ixazomib 1 MG

    Takeda

    Human Immunodeficiency Virus (HIV)

    phase 2 · small molecule · completed

    1 trial →

30. JNJ-73763989

    Janssen Cilag International NV

    Hepatitis B, Chronic

    phase 2 · small molecule · terminated

    1 trial →

31. JSVCT099

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 · mab · completed

    1 trial →

32. K-001-201

    The George Institute

    Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis

    phase 2 · small molecule · active

    1 trial →

33. KAE609

    Novartis Pharmaceuticals

    Malaria

    phase 2 · small molecule · completed

    1 trial →

34. KAF156

    Novartis Pharmaceuticals

    Acute Uncomplicated Plasmodium Falciparum Malaria

    phase 2 · small molecule · completed

    1 trial →

35. KAF156

    Novartis Pharmaceuticals

    Malaria

    phase 2 · small molecule · completed

    1 trial →

36. KLWS-V502-02

    BRIGHT MINDS BIOSCIENCES INC.

    Human Papilloma Virus Infection

    phase 2 · mab · completed

    1 trial →

37. LIK066

    Novartis Pharmaceuticals

    Obese Patients With Non-alcoholic Steatohepatitis (NASH)

    phase 2 · small molecule · completed

    1 trial →

38. LP-98 20 mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV

    phase 2 · small molecule · active

    1 trial →

39. Late immunity following single immunization with GA2 sporozoites (GACHA)

    Disc Medicine

    Falciparum malaria

    phase 2 · other · active

    1 trial →

40. Lucinactant

    WINDTREE THERAPEUTICS INC /DE/

    COVID-19

    phase 2 · small molecule · completed

    1 trial →

41. Lumicitabine

    Janssen Cilag International NV

    Respiratory Syncytial Virus Infections

    phase 2 · small molecule · completed

    1 trial →

42. M19-965

    AbbVie Deutschland GmbH & Co. KG

    HIV infection

    phase 2 · small molecule · active

    1 trial →

43. MAU868

    Vera Therapeutics

    BK Virus Infection

    phase 2 · small molecule · completed

    1 trial →

44. MEDI8897

    MedImmune

    Respiratory Syncytial Virus Infections

    phase 2 · small molecule · completed

    1 trial →

45. MGL-3196

    Madrigal Pharmaceuticals EU Limited

    Non-alcoholic Steatohepatitis

    phase 2 · small molecule · completed

    1 trial →

46. MK-5592-127

    Merck Sharp and Dohme

    Fungal infection

    phase 2 · small molecule · active

    1 trial →

47. MK-6024-017

    Merck Sharp and Dohme

    Metabolic Dysfunction-Associated Steatohepatitis

    phase 2 · small molecule · active

    1 trial →

48. MK-8591-013

    Merck Sharp and Dohme

    HIV-1 Infection

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions